Tumor-educated B cells selectively promote breast cancer lymph node metastasis by HSPA4-targeting IgG

Primary tumors may create the premetastatic niche in secondary organs for subsequent metastasis. Humoral immunity contributes to the progression of certain cancers, but the roles of B cells and their derived antibodies in premetastatic niche formation are poorly defined. Using a mouse model of spont...

Full description

Saved in:
Bibliographic Details
Published inNature medicine Vol. 25; no. 2; pp. 312 - 322
Main Authors Gu, Yan, Liu, Yanfang, Fu, Li, Zhai, Lili, Zhu, Jie, Han, Yanmei, Jiang, Yingming, Zhang, Yi, Zhang, Peng, Jiang, Zhengping, Zhang, Xiang, Cao, Xuetao
Format Journal Article
LanguageEnglish
Published New York Nature Publishing Group US 01.02.2019
Nature Publishing Group
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Primary tumors may create the premetastatic niche in secondary organs for subsequent metastasis. Humoral immunity contributes to the progression of certain cancers, but the roles of B cells and their derived antibodies in premetastatic niche formation are poorly defined. Using a mouse model of spontaneous lymph node metastasis of breast cancer, we show that primary tumors induced B cell accumulation in draining lymph nodes. These B cells selectively promoted lymph node metastasis by producing pathogenic IgG that targeted glycosylated membrane protein HSPA4, and activated the HSPA4-binding protein ITGB5 and the downstream Src/NF-κB pathway in tumor cells for CXCR4/SDF1α-axis-mediated metastasis. High serum anti-HSPA4 IgG was correlated with high tumor HSPA4 expression and poor prognosis of breast cancer subjects. Our findings identify a key role for tumor-educated B cells and their derived antibodies in lymph node premetastatic niche formation, providing potential targets for cancer intervention. B cells facilitate breast cancer metastasis to lymph nodes through production of antibodies targeting a protein on the surface of cancer cells that stimulates tumor dissemination.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ISSN:1078-8956
1546-170X
1546-170X
DOI:10.1038/s41591-018-0309-y